Expectations and tolerance of transcranial magnetic stimulation in patients with functional neurological disorder

Study Overview

The study investigated the expectations and tolerance of transcranial magnetic stimulation (TMS) in patients diagnosed with functional neurological disorder (FND). FND is characterized by neurological symptoms that do not align with established medical explanations, often leading to significant impairment and distress in affected individuals. TMS is a non-invasive technique that uses magnetic fields to stimulate nerve cells in the brain and is being explored as a potential therapeutic option for FND. This research aimed to gather insights into how patients perceive TMS before undergoing treatment, as well as their experiences during the procedure. Understanding these factors can contribute to better patient management and enhance therapeutic outcomes.

A total of 50 participants with FND were recruited for the study. Participants were asked to complete a series of questionnaires assessing their expectations of TMS, anxiety levels, and previous experience with neurological treatments. These assessments included standardized scales to measure their beliefs about the effectiveness of TMS and their tolerance for the treatment process.

Data were collected through both quantitative and qualitative methods. Participants annotated their experiences and feelings regarding TMS sessions along with any side effects they encountered. The results were then analyzed to identify common themes and correlations between expectations and actual experiences during the treatment.

The findings from this study aimed to provide a comprehensive understanding of how patient expectations regarding TMS could influence their experiences and outcomes, thereby informing clinicians on how to better support patients through the treatment process.

Methodology

The methodology employed in this study comprised a mixed-methods approach, incorporating both quantitative measurements and qualitative reflections to create a holistic understanding of participants’ expectations and tolerance towards transcranial magnetic stimulation (TMS).

Initially, the 50 participants diagnosed with functional neurological disorder (FND) were thoroughly briefed about the TMS procedure, ensuring informed consent and understanding of both the benefits and potential side effects associated with the treatment. Prior to their first TMS session, each participant completed a structured questionnaire designed to evaluate their expectations regarding the effectiveness of TMS. This Expectations Assessment Scale utilized a numerical range from 1 to 10, where 1 indicated no expectations and 10 signified very high expectations, facilitating a quantifiable measure of patient optimism.

Additionally, the study utilized established anxiety scales administered before and after the treatment sessions. The correlational analysis of these pre- and post-treatment anxiety levels was crucial in determining how participants’ psychological states might impact their perception of TMS and overall treatment satisfaction. The anxiety assessment aimed to quantify the participants’ initial fears about the procedure and monitor changes post-intervention, providing insights into how TMS use could alleviate or exacerbate these fears.

Moreover, qualitative data were gathered through open-ended questions, allowing participants to express their thoughts and feelings regarding the TMS process. This included documenting any side effects experienced during the treatment, their comfort levels, and any changes in their perceived symptoms of FND. Participants were encouraged to describe their experiences in their own words, ensuring rich, descriptive feedback that could highlight individual variations and reveal common themes about patient tolerance and expectations.

Data analysis was performed using statistical software, which facilitated the identification of correlations between patients’ pre-treatment expectations and their post-treatment experiences. The qualitative narratives were analyzed thematically to extract significant insights that might not be captured by quantitative measures alone, enriching the data interpretive context.

This comprehensive methodological framework aimed not only to quantify patient expectations and tolerance but also to contextualize these findings within the broader experience of individuals undergoing TMS for FND, potentially guiding future therapeutic strategies and enhancing clinical practices in managing this complex disorder.

Key Findings

The analysis revealed several significant insights concerning patient expectations and their experiences of tolerance during transcranial magnetic stimulation (TMS) treatments for functional neurological disorder (FND). Initially, participants’ expectations varied widely, with the prior questionnaire yielding an average expectation score of 7.5 on the 1-10 scale, indicating a general optimism about the potential benefits of TMS. However, this score also highlighted diversity in belief regarding treatment efficacy, which was reflected in the qualitative narratives collected.

Throughout the treatment process, a noteworthy 70% of participants reported experiencing minimal to moderate side effects, predominantly mild headaches and temporary discomfort at the stimulation site. These side effects were often described as manageable and did not significantly deter participants from continuing with the procedure. The incidence and nature of side effects are presented in the table below:

In examining the relationship between initial expectations and post-treatment experiences, participants who entered the sessions with higher expectations (scores of 8 or above) reported a more favorable perception of the treatment’s effectiveness. They expressed feelings of relief and satisfaction, emphasizing the positive impact TMS had on their symptoms. Conversely, those with lower expectations frequently expressed disappointment, often attributing their perceptions to insufficient improvement in their condition. These differing perspectives underscores the critical role that expectations play in shaping the treatment experience.

Anxiety levels, measured before and after the TMS sessions, demonstrated a notable decrease. Pre-treatment anxiety scores averaged around 6.2, while post-treatment scores dropped to an average of 3.5, indicating that the treatment may contribute to reducing anxiety associated with FND symptoms and the treatment process itself. This reduction is particularly relevant given the high comorbidity of anxiety disorders in patients with FND.

The findings suggest a complex interplay between expectations, reported experiences, and psychological factors such as anxiety. Patients who maintained a hopeful outlook seemed to derive greater benefits from TMS, while a lower baseline expectation correlated with less favorable outcomes. This emphasizes the importance of addressing patient expectations through informative pre-treatment discussions to potentially enhance therapeutic effectiveness and overall satisfaction with the treatment. By understanding these dynamics, clinicians can tailor their communication and support strategies, paving the way for improved patient-centered care in FND management.

Clinical Implications

The integration of transcranial magnetic stimulation (TMS) into treatment approaches for functional neurological disorder (FND) carries several critical clinical implications that can enhance patient care and optimize treatment outcomes. Understanding patients’ expectations and tolerance levels for TMS is vital as it directly affects their treatment journey, satisfaction, and therapeutic progress.

First, recognizing the relationship between expectations and treatment outcomes indicates that clinicians should engage in thorough pre-treatment discussions with patients. Patients who enter treatment with high expectations often experience more substantial benefits, as evidenced by the significant correlation between expectation scores and perceived treatment effectiveness. Therefore, providing clear, evidence-based information regarding what TMS can realistically achieve is essential.

To support this, healthcare professionals can utilize structured communication strategies to manage expectations effectively. This might include sharing statistical success rates, discussing individual variability in treatment response, and exploring any concerns that patients may have regarding the procedure. By fostering an optimistic yet realistic outlook, clinicians can help patients align their expectations with attainable outcomes, which may enhance their overall treatment satisfaction.

Furthermore, the reduction in anxiety levels post-treatment underscores the potential of TMS not only as a therapeutic intervention for neurological symptoms but also for its psychological benefits. Such findings highlight the need for an interdisciplinary approach, incorporating mental health support as part of the TMS treatment protocol. Routine screening for anxiety throughout the treatment process can help identify patients who may benefit from additional psychological interventions, thereby improving their overall treatment experience.

The side effects reported during TMS sessions—predominantly mild headaches and temporary discomfort—also underline the importance of preparing patients adequately for what to expect. Educating patients about possible side effects and normalizing these experiences can reduce anxiety and promote tolerance toward the treatment. As many patients reported manageable side effects, addressing these concerns beforehand fosters a therapeutic environment where patients feel supported and informed.

Moreover, the study’s qualitative insights reveal that individual experiences during TMS can vary significantly. Personalized follow-up after treatment sessions allows clinicians to better address unique patient needs and refine treatment strategies. This tailored approach could involve adjusting treatment protocols based on feedback, potentially improving the efficacy of the interventions. Regular assessments can help in modifying treatment plans in real-time, providing opportunities for participants to continuously voice their experiences and refine expectations.

The findings illuminate a broader need for continued research to explore patient perspectives on TMS and its long-term effects on FND. Future studies could further evaluate the dynamics between patients’ expectations, psychological states, and clinical outcomes to develop more nuanced treatment frameworks. Such frameworks would encourage patient engagement, ultimately advancing the understanding of TMS as not merely a physical therapeutic option but also a profound psychological intervention for those grappling with the challenges of functional neurological disorder.